CytomX Therapeutics CTMX
NASDAQ CTMX
$2.63 -0.09 (-3.31%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Shares Outstanding (Diluted) (2019 - 2026)

Updated

CytomX Therapeutics (CTMX) recorded Shares Outstanding (Diluted) of 218.94 million in Q2 2026, up 69.6% from 129.08 million a year earlier and up 23.5% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends

For FY2025, CytomX Therapeutics reported Shares Outstanding (Diluted) of 137.94 million, up 62.8% from FY2024.

  • Annual Shares Outstanding (Diluted) has increased for six straight years, with a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Diluted) came in at 84.75 million in FY2024 (+14.8%), 73.81 million in FY2023 (+12.3%), 65.74 million in FY2022 (+2.5%) and 64.15 million in FY2021 (+39.0%).
  • The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2019.
  • On a year-over-year basis, Shares Outstanding (Diluted) has increased for 26 consecutive quarters, with growth averaging 50.9% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.7% in Q2 2022 to 103.4% in Q1 2026.
  • Per Business Quant, the preceding three quarters came in at 177.27 million (Q1 2026), 137.94 million (Q4 2025) and 165 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.44 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.96 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.56 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 544.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 255.20 Mn
10 CytomX Therapeutics 592.69 Mn -364.98 Mn - 218.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 218.94 Mn
Mar 31, 2026 177.27 Mn
Dec 31, 2025 137.94 Mn
Sep 30, 2025 165.00 Mn
Jun 30, 2025 129.08 Mn
Mar 31, 2025 87.15 Mn
Dec 31, 2024 84.75 Mn
Sep 30, 2024 85.20 Mn
Jun 30, 2024 84.88 Mn
Mar 31, 2024 82.63 Mn
Dec 31, 2023 73.81 Mn
Sep 30, 2023 80.99 Mn
Jun 30, 2023 66.54 Mn
Mar 31, 2023 66.25 Mn
Dec 31, 2022 65.74 Mn
Sep 30, 2022 65.91 Mn
Jun 30, 2022 65.54 Mn
Mar 31, 2022 65.39 Mn
Dec 31, 2021 64.15 Mn
Sep 30, 2021 65.21 Mn
API Access

CytomX Therapeutics Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CTMX&period=max&api_key=YOUR_API_KEY